ba.4-5 booster Search Results


90
Pfizer Inc 3rd booster by pfizer (ba.4/5)
Characteristics of Patients in Study Cohort
3rd Booster By Pfizer (Ba.4/5), supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/3rd booster by pfizer (ba.4/5)/product/Pfizer Inc
Average 90 stars, based on 1 article reviews
3rd booster by pfizer (ba.4/5) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Pfizer Inc ba.5 bivalent booster
Characteristics of Patients in Study Cohort
Ba.5 Bivalent Booster, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ba.5 bivalent booster/product/Pfizer Inc
Average 90 stars, based on 1 article reviews
ba.5 bivalent booster - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Pfizer Inc pfizer ba.4-5 booster
Characteristics of Patients in Study Cohort
Pfizer Ba.4 5 Booster, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pfizer ba.4-5 booster/product/Pfizer Inc
Average 90 stars, based on 1 article reviews
pfizer ba.4-5 booster - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Moderna 2nd booster by moderna (ba.1)
Characteristics of Patients in Study Cohort
2nd Booster By Moderna (Ba.1), supplied by Moderna, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/2nd booster by moderna (ba.1)/product/Moderna
Average 90 stars, based on 1 article reviews
2nd booster by moderna (ba.1) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
BioNTech mrna second bivalent or monovalent booster containing various spike inserts [prototype (ancestral), beta, delta, and/or omicron ba.1 or ba.4/5]
Characteristics of Patients in Study Cohort
Mrna Second Bivalent Or Monovalent Booster Containing Various Spike Inserts [Prototype (Ancestral), Beta, Delta, And/Or Omicron Ba.1 Or Ba.4/5], supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mrna second bivalent or monovalent booster containing various spike inserts [prototype (ancestral), beta, delta, and/or omicron ba.1 or ba.4/5]/product/BioNTech
Average 90 stars, based on 1 article reviews
mrna second bivalent or monovalent booster containing various spike inserts [prototype (ancestral), beta, delta, and/or omicron ba.1 or ba.4/5] - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Sanofi sanofi/gsk bivalent ba.4-5 booster
Characteristics of Patients in Study Cohort
Sanofi/Gsk Bivalent Ba.4 5 Booster, supplied by Sanofi, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sanofi/gsk bivalent ba.4-5 booster/product/Sanofi
Average 90 stars, based on 1 article reviews
sanofi/gsk bivalent ba.4-5 booster - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Moderna moderna ba.4-5 booster
Characteristics of Patients in Study Cohort
Moderna Ba.4 5 Booster, supplied by Moderna, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/moderna ba.4-5 booster/product/Moderna
Average 90 stars, based on 1 article reviews
moderna ba.4-5 booster - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Moderna 3rd booster by moderna (ba.4/5)
Characteristics of Patients in Study Cohort
3rd Booster By Moderna (Ba.4/5), supplied by Moderna, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/3rd booster by moderna (ba.4/5)/product/Moderna
Average 90 stars, based on 1 article reviews
3rd booster by moderna (ba.4/5) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Moderna bivalent (ancestral and omicron ba.4/5) booster vaccine
Characteristics of Patients in Study Cohort
Bivalent (Ancestral And Omicron Ba.4/5) Booster Vaccine, supplied by Moderna, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bivalent (ancestral and omicron ba.4/5) booster vaccine/product/Moderna
Average 90 stars, based on 1 article reviews
bivalent (ancestral and omicron ba.4/5) booster vaccine - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Sanofi sanofi/gsk bivalent ba.4-5 boosters
Characteristics of Patients in Study Cohort
Sanofi/Gsk Bivalent Ba.4 5 Boosters, supplied by Sanofi, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sanofi/gsk bivalent ba.4-5 boosters/product/Sanofi
Average 90 stars, based on 1 article reviews
sanofi/gsk bivalent ba.4-5 boosters - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Urschel Laboratories ba4/5 bivalent mrna booster vaccines
Characteristics of Patients in Study Cohort
Ba4/5 Bivalent Mrna Booster Vaccines, supplied by Urschel Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ba4/5 bivalent mrna booster vaccines/product/Urschel Laboratories
Average 90 stars, based on 1 article reviews
ba4/5 bivalent mrna booster vaccines - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Sanofi sanofi/gsk ba.4-5 boosters
Characteristics of Patients in Study Cohort
Sanofi/Gsk Ba.4 5 Boosters, supplied by Sanofi, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sanofi/gsk ba.4-5 boosters/product/Sanofi
Average 90 stars, based on 1 article reviews
sanofi/gsk ba.4-5 boosters - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Characteristics of Patients in Study Cohort

Journal: Open Forum Infectious Diseases

Article Title: Bivalent Vaccine Effectiveness Among Adults Aged ≥65 Years During the BA.5-Predominant Period in Japan: The VENUS Study

doi: 10.1093/ofid/ofad475

Figure Lengend Snippet: Characteristics of Patients in Study Cohort

Article Snippet: 3rd Booster by Pfizer (BA.4/5) , 46 500 (56.7).

Techniques: Infection

Vaccine Effectiveness After the Second or Third Booster Doses by Bivalent Vaccine Among Adults Aged ≥65 Years During Omicron BA.5 Predominance

Journal: Open Forum Infectious Diseases

Article Title: Bivalent Vaccine Effectiveness Among Adults Aged ≥65 Years During the BA.5-Predominant Period in Japan: The VENUS Study

doi: 10.1093/ofid/ofad475

Figure Lengend Snippet: Vaccine Effectiveness After the Second or Third Booster Doses by Bivalent Vaccine Among Adults Aged ≥65 Years During Omicron BA.5 Predominance

Article Snippet: 3rd Booster by Pfizer (BA.4/5) , 46 500 (56.7).

Techniques: Infection

Characteristics of Patients in Study Cohort

Journal: Open Forum Infectious Diseases

Article Title: Bivalent Vaccine Effectiveness Among Adults Aged ≥65 Years During the BA.5-Predominant Period in Japan: The VENUS Study

doi: 10.1093/ofid/ofad475

Figure Lengend Snippet: Characteristics of Patients in Study Cohort

Article Snippet: 2nd Booster by Moderna (BA.1) , 35 (0.0).

Techniques: Infection

Vaccine Effectiveness After the Second or Third Booster Doses by Bivalent Vaccine Among Adults Aged ≥65 Years During Omicron BA.5 Predominance

Journal: Open Forum Infectious Diseases

Article Title: Bivalent Vaccine Effectiveness Among Adults Aged ≥65 Years During the BA.5-Predominant Period in Japan: The VENUS Study

doi: 10.1093/ofid/ofad475

Figure Lengend Snippet: Vaccine Effectiveness After the Second or Third Booster Doses by Bivalent Vaccine Among Adults Aged ≥65 Years During Omicron BA.5 Predominance

Article Snippet: 2nd Booster by Moderna (BA.1) , 35 (0.0).

Techniques: Infection

Characteristics of Patients in Study Cohort

Journal: Open Forum Infectious Diseases

Article Title: Bivalent Vaccine Effectiveness Among Adults Aged ≥65 Years During the BA.5-Predominant Period in Japan: The VENUS Study

doi: 10.1093/ofid/ofad475

Figure Lengend Snippet: Characteristics of Patients in Study Cohort

Article Snippet: 3rd Booster by Moderna (BA.4/5) , 1425 (1.7).

Techniques: Infection

Vaccine Effectiveness After the Second or Third Booster Doses by Bivalent Vaccine Among Adults Aged ≥65 Years During Omicron BA.5 Predominance

Journal: Open Forum Infectious Diseases

Article Title: Bivalent Vaccine Effectiveness Among Adults Aged ≥65 Years During the BA.5-Predominant Period in Japan: The VENUS Study

doi: 10.1093/ofid/ofad475

Figure Lengend Snippet: Vaccine Effectiveness After the Second or Third Booster Doses by Bivalent Vaccine Among Adults Aged ≥65 Years During Omicron BA.5 Predominance

Article Snippet: 3rd Booster by Moderna (BA.4/5) , 1425 (1.7).

Techniques: Infection